NO20016378L - Kinolinkarboksylsyrederivater eller salter derav - Google Patents

Kinolinkarboksylsyrederivater eller salter derav

Info

Publication number
NO20016378L
NO20016378L NO20016378A NO20016378A NO20016378L NO 20016378 L NO20016378 L NO 20016378L NO 20016378 A NO20016378 A NO 20016378A NO 20016378 A NO20016378 A NO 20016378A NO 20016378 L NO20016378 L NO 20016378L
Authority
NO
Norway
Prior art keywords
carboxylic acid
salts
acid derivatives
quinoline carboxylic
extremely high
Prior art date
Application number
NO20016378A
Other languages
English (en)
Other versions
NO321803B1 (no
NO20016378D0 (no
Inventor
Akira Yazaki
Yoshiko Niino
Yasuhiro Kuramoto
Yuzo Hirao
Yoshihiro Ohshita
Norihiro Hayashi
Hirotaka Amano
Original Assignee
Wakunaga Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharma Co Ltd filed Critical Wakunaga Pharma Co Ltd
Publication of NO20016378D0 publication Critical patent/NO20016378D0/no
Publication of NO20016378L publication Critical patent/NO20016378L/no
Publication of NO321803B1 publication Critical patent/NO321803B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20016378A 1999-07-01 2001-12-27 Kinolinkarboksylsyrederivater eller salter derav, medikament eller medikamentblanding som omfatter dem, samt anvendelse derav NO321803B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18749299 1999-07-01
PCT/JP2000/004096 WO2001002390A1 (fr) 1999-07-01 2000-06-22 Derive d'acide quinolinecarboxylique et ses sels

Publications (3)

Publication Number Publication Date
NO20016378D0 NO20016378D0 (no) 2001-12-27
NO20016378L true NO20016378L (no) 2002-02-28
NO321803B1 NO321803B1 (no) 2006-07-03

Family

ID=16207019

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016378A NO321803B1 (no) 1999-07-01 2001-12-27 Kinolinkarboksylsyrederivater eller salter derav, medikament eller medikamentblanding som omfatter dem, samt anvendelse derav

Country Status (25)

Country Link
US (1) US6858625B1 (no)
EP (1) EP1193266B1 (no)
JP (1) JP3477465B2 (no)
KR (1) KR100628414B1 (no)
CN (1) CN1157389C (no)
AT (1) ATE248162T1 (no)
AU (1) AU766014B2 (no)
BR (1) BR0012192A (no)
CA (1) CA2376760C (no)
CZ (1) CZ302033B6 (no)
DE (1) DE60004846T2 (no)
DK (1) DK1193266T3 (no)
ES (1) ES2206257T3 (no)
HK (1) HK1047103B (no)
HU (1) HUP0201549A3 (no)
IL (2) IL147043A0 (no)
MX (1) MXPA02000103A (no)
NO (1) NO321803B1 (no)
NZ (1) NZ516201A (no)
PT (1) PT1193266E (no)
RU (1) RU2236408C2 (no)
SK (1) SK285814B6 (no)
TW (1) TW576832B (no)
WO (1) WO2001002390A1 (no)
ZA (1) ZA200110357B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3477466B2 (ja) * 1999-09-02 2003-12-10 湧永製薬株式会社 キノリンカルボン酸誘導体又はその塩
US7172535B2 (en) * 2004-10-28 2007-02-06 Volmar John F Upper back exercise machine and method of use
MX2007005892A (es) * 2004-11-17 2007-06-19 Wakunaga Pharma Co Ltd Derivados de acido piridonacarboxilico novedosos y sales de los mismos.
ES2966093T3 (es) * 2008-09-24 2024-04-18 Melinta Subsidiary Corp Formulación farmacéutica que contiene un derivado de quinolona

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO177302C (no) * 1989-03-16 1995-08-23 Esteve Labor Dr Analogifremgangsmåte til fremstilling av terapeutisk aktive substituerte azetidinylkinolon(naftyridon)karboksylsyrederivater
WO1995005373A1 (en) 1993-08-13 1995-02-23 Dong Wha Pharmaceutical Industrial Co., Ltd. Novel quinolone carboxylic acid derivatives
ES2183473T3 (es) * 1995-09-22 2003-03-16 Wakunaga Pharma Co Ltd Derivados de acido piridonacarboxilico como agentes antibacterianos.
US6211375B1 (en) 1996-04-19 2001-04-03 Wakunaga Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents containing the same as the active ingredient
JP3448305B2 (ja) 1996-11-28 2003-09-22 湧永製薬株式会社 新規ピリドンカルボン酸誘導体又はその塩及びこれを有効成分とする医薬
DE19652239A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
JPH11292873A (ja) 1998-04-07 1999-10-26 Dainippon Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法およびその中間体

Also Published As

Publication number Publication date
HK1047103B (zh) 2005-04-08
CZ20014598A3 (cs) 2002-05-15
AU5567900A (en) 2001-01-22
NZ516201A (en) 2003-06-30
ZA200110357B (en) 2002-12-18
DE60004846D1 (de) 2003-10-02
JP3477465B2 (ja) 2003-12-10
AU766014B2 (en) 2003-10-09
TW576832B (en) 2004-02-21
DE60004846T2 (de) 2004-06-03
IL147043A (en) 2007-07-04
ES2206257T3 (es) 2004-05-16
BR0012192A (pt) 2002-06-18
DK1193266T3 (da) 2003-11-24
NO321803B1 (no) 2006-07-03
RU2236408C2 (ru) 2004-09-20
CA2376760A1 (en) 2001-01-11
IL147043A0 (en) 2002-08-14
CA2376760C (en) 2008-11-25
NO20016378D0 (no) 2001-12-27
ATE248162T1 (de) 2003-09-15
MXPA02000103A (es) 2003-07-21
KR100628414B1 (ko) 2006-09-26
EP1193266A4 (en) 2002-08-14
EP1193266B1 (en) 2003-08-27
PT1193266E (pt) 2003-12-31
CZ302033B6 (cs) 2010-09-08
CN1358183A (zh) 2002-07-10
HUP0201549A2 (en) 2002-08-28
HK1047103A1 (en) 2003-02-07
SK19162001A3 (sk) 2002-06-04
HUP0201549A3 (en) 2003-11-28
SK285814B6 (sk) 2007-08-02
WO2001002390A1 (fr) 2001-01-11
KR20020020733A (ko) 2002-03-15
CN1157389C (zh) 2004-07-14
EP1193266A1 (en) 2002-04-03
US6858625B1 (en) 2005-02-22

Similar Documents

Publication Publication Date Title
AR048859A1 (es) Utilizacion de derivados de indazol carboxamidas para la preparacion de un medicamento destinado al tratamiento y a la prevencion del paludismo
ATE309194T1 (de) Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
HUP0400781A2 (hu) Eljárás (R)- vagy (S)-lansoprazol kristályosítására, az előállított kristályok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
HUE063556T2 (hu) [(1,5-difenil-1H-1,2,4-triazol-3-il)oxi]ecetsav-származékok és ezek sói, ezeket tartalmazó növényvédõszer haszon- vagy kultúrnövényekhez, eljárás ezek elõállítására és alkalmazásuk széfenerként
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
HUT70482A (en) Immunopotentiatory pharmaceutical compositions containing carbonylgroups
FI945776A (fi) Yhden astian menetelmä 3-kinolonikarboksyylihaapojohdannaisten valmistamiseksi
KR870006034A (ko) 항균제로서의 5-아미노 및 5-하이드록시- 6,8-디플루오로퀴놀론
NO884958L (no) Kinolinkarboksylsyrederivater.
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
IL101009A0 (en) 2-substituted quinolines,preparation and pharmaceutical compositions containing them
NO20016378D0 (no) Quinolinkarboksylsyrederivater eller salter derav
KR950700281A (ko) 퀴놀론카르복실산 유도체 수화물 결정(crystal of quinolonecarboxylic acid derivative hydrate)
DE602004009079D1 (de) Carbostyril-derivative zur beschleunigten speichelabsonderung
HUP0401562A2 (hu) Kinolinszármazékok és alkalmazásuk tumorellenes szerekként és ezeket tartalmazó gyógyászati készítmények
UA91549C2 (ru) Производные хинолина как антибактериальные агенты
JP3424038B2 (ja) 合成抗菌剤水性組成物
JPS63188626A (ja) ピリドンカルボン酸の可溶化方法
RU2002102491A (ru) Производные хинолинкарбоновой кислоты или их соли
CY1110244T1 (el) Χαμηλης υγροσκοπικοτητας αριπιπραζολη ως φαρμακευτικη ουσια και μεθοδοι για την παρασκευη της
EP1219618A4 (en) QUINOLINECARBOXYLIC ACID DERIVATIVE OR ITS SALT
RU2007122499A (ru) Новые производные пиридонкарбоновой кислоты или их соли
KR920006345A (ko) 신규한 퀴놀론 카르복실산 유도체
WO2003013530A3 (de) Salze substituierter 1,2,3,4,-tetrahydrochinolin-2-carbonsaurederivate als nmda-antagonisten
JPH0459726A (ja) ピリドンカルボン酸の可溶化方法

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees